Al Phahelix Biometrics, Incorporated: Company Profile

Background

Overview

Al Phahelix Biometrics, Incorporated is a privately held corporation founded in 2011 and based in Boerne, Texas. The company specializes in the development and application of biometric technologies, focusing on individualized medicine. Its mission is to advance personalized healthcare solutions through innovative biometric applications. The company's vision is to revolutionize medical diagnostics and treatment by integrating biometric data into personalized healthcare strategies. Operating within the biotechnology and healthcare industries, Al Phahelix Biometrics holds a significant position in the emerging field of biometric-based medical solutions.

Key Strategic Focus

Core Objectives

Al Phahelix Biometrics aims to leverage biometric technologies to enhance personalized medicine, focusing on improving diagnostic accuracy and treatment efficacy.

Areas of Specialization

The company specializes in the integration of biometric data into medical applications, emphasizing individualized healthcare solutions.

Key Technologies Utilized

Al Phahelix employs advanced biometric technologies, including facial recognition, fingerprint analysis, and other physiological measurements, to develop personalized medical applications.

Primary Markets Targeted

The company's primary markets include healthcare providers, research institutions, and pharmaceutical companies seeking innovative solutions for personalized medicine.

Financials and Funding

Funding History

Specific details regarding Al Phahelix Biometrics' funding history, total funds raised, and recent funding rounds are not publicly disclosed.

Notable Investors

Information about notable investors in Al Phahelix Biometrics is not publicly available.

Utilization of Capital

The company utilizes its capital to fund research and development initiatives, focusing on the integration of biometric technologies into medical applications.

Pipeline Development

Key Pipeline Candidates

Al Phahelix Biometrics is engaged in the development of biometric-based medical solutions, though specific pipeline candidates are not publicly detailed.

Stages of Development

The company is in the research and development phase, working on integrating biometric data into personalized healthcare applications.

Target Conditions

Al Phahelix focuses on medical conditions that can benefit from personalized treatment plans informed by biometric data, though specific conditions are not specified.

Anticipated Milestones

Specific timelines for anticipated milestones in the company's development pipeline are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies

Al Phahelix has developed proprietary biometric technologies tailored for medical applications, though detailed descriptions are not publicly available.

Significant Scientific Methods

The company employs advanced biometric analysis techniques, including facial recognition and fingerprint analysis, to inform personalized medical treatments.

AI-Driven Capabilities

Al Phahelix integrates artificial intelligence with biometric data to enhance the accuracy and effectiveness of personalized healthcare solutions.

Leadership Team

Clyde F. Phelix, PhD – Vice President and Chair of Board

Dr. Phelix holds an A.A.S in Medical Laboratory Technology, a B.A. in Biology, and a PhD in Human Anatomy and Neuroscience from the University of Missouri – Columbia. He completed postdoctoral training in Physiology, Pharmacology, and Toxicology at the University of Georgia – Athens. Currently, he is a Professor in the Biology Department at the University of Texas – San Antonio (UTSA) and serves as the instructor for Ethics, Biostatistics, and Regulatory GxPs in the graduate Biotechnology Program at UTSA. Dr. Phelix is also the founder and owner of CFPAL Biomedical Consultants and has experience as a Clinical Laboratory Director and Technical Consultant.

Richard G. LeBaron, PhD – Secretary and Board Member

Dr. LeBaron earned his B.S. in Biology from Louisiana State University in Shreveport and his PhD from the University of Alabama in Birmingham. He completed postdoctoral research at the Burnham Institute in La Jolla, CA. Dr. LeBaron has served as a Senior Research Scientist at Advanced Tissue Sciences and is currently a Full Professor in the Department of Biology at the University of Texas at San Antonio. He is a founder, officer, and board member of Al Phahelix Biometrics and serves as a consultant for Southwest Clinical Laboratories.

Dawnlee J. Roberson, MBA, PhD – President and Board Member

Dr. Roberson holds a B.S. in Biology, an M.S. in Electrical Engineering, and an MBA from The University of Texas at San Antonio. She earned her Ph.D. in Biomedical Engineering from The University of Texas at Austin. After postdoctoral training, she held a faculty position in the Department of Biomedical Engineering at UTSA. Dr. Roberson is a Senior Member of the IEEE and has served in the US Air Force Reserves for many years. She is a founder, president, and board member of Al Phahelix Biometrics.

Competitor Profile

Market Insights and Dynamics

The biometric technology market is experiencing significant growth, driven by increasing demand for secure and personalized healthcare solutions. Advancements in AI and machine learning are enhancing the capabilities of biometric applications in medicine.

Competitor Analysis

Al Phahelix Biometrics operates in a competitive landscape with several key players:

FacePhi Biometría: A Spanish company specializing in biometric identity verification solutions, with a strong presence in the financial sector.

Biometrics Ltd: A UK-based company providing advanced sensors and software for biomedical and engineering research, with a focus on data acquisition systems.

Aluf Holdings, Inc.: A US-based holding company focusing on acquiring and managing companies in the biometrics and blockchain sectors, with a strategic emphasis on biometric technologies.

Strategic Collaborations and Partnerships

Al Phahelix Biometrics has established collaborations with academic institutions, including the University of Texas at San Antonio, to advance research in biometric applications for personalized medicine.

Operational Insights

The company differentiates itself through its focus on integrating biometric technologies into personalized healthcare solutions, leveraging the expertise of its leadership team in both biomedical engineering and biology.

Strategic Opportunities and Future Directions

Al Phahelix Biometrics is well-positioned to capitalize on the growing demand for personalized medicine by expanding its biometric applications and forming strategic partnerships with healthcare providers and research institutions.